An Investigator-initiated Clinical Study of LM303 Injection for the Treatment of Advanced Solid Tumours
Clinical trial NCT06695689 · RECRUITING
Trial details
- NCT number
- NCT06695689
- Sponsor
- Suzhou BlueHorse Therapeutics Co., Ltd.
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-17
- Primary completion
- 2026-10-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.